×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
APLT – applied therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
APLT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/3
11:00 am
aplt
Small Caps Suffer Under Tariff Wave as Russell Hits Bear Market [Yahoo! Finance]
Low
Report
Small Caps Suffer Under Tariff Wave as Russell Hits Bear Market [Yahoo! Finance]
3/31
07:10 am
aplt
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
Medium
Report
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
3/19
08:07 pm
aplt
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer [Yahoo! Finance]
Low
Report
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer [Yahoo! Finance]
3/19
07:00 am
aplt
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
Low
Report
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
2/18
02:22 pm
aplt
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
Low
Report
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
2/18
11:53 am
aplt
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
Medium
Report
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
2/18
11:12 am
aplt
DEADLINE ALERT for APLT and KSPI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Medium
Report
DEADLINE ALERT for APLT and KSPI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
2/18
08:36 am
aplt
APLT FRAUD ALERT: A Class Action has been Filed against Applied Therapeutics for Securities Fraud – Contact BFA Law by Today’s Deadline (NASDAQ:APLT)
High
Report
APLT FRAUD ALERT: A Class Action has been Filed against Applied Therapeutics for Securities Fraud – Contact BFA Law by Today’s Deadline (NASDAQ:APLT)
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/31
07:00 am
aplt
Form NT 10-K Applied Therapeutics, For: Dec 31
Medium
Report
Form NT 10-K Applied Therapeutics, For: Dec 31
3/26
08:25 pm
aplt
Form 4 Applied Therapeutics, For: Mar 24 Filed by: Hooks Corwin Dale
Medium
Report
Form 4 Applied Therapeutics, For: Mar 24 Filed by: Hooks Corwin Dale
3/26
08:21 pm
aplt
Form 4 Applied Therapeutics, For: Mar 24 Filed by: Funtleyder Leslie D.
Medium
Report
Form 4 Applied Therapeutics, For: Mar 24 Filed by: Funtleyder Leslie D.
3/26
08:15 pm
aplt
Form 4 Applied Therapeutics, For: Mar 24 Filed by: Chinoporos Constantine
Medium
Report
Form 4 Applied Therapeutics, For: Mar 24 Filed by: Chinoporos Constantine
3/6
08:31 pm
aplt
Form 4 Applied Therapeutics, For: Mar 04 Filed by: Perfetti Riccardo
High
Report
Form 4 Applied Therapeutics, For: Mar 04 Filed by: Perfetti Riccardo
3/6
08:30 pm
aplt
Form 4 Applied Therapeutics, For: Mar 04 Filed by: Funtleyder Leslie D.
High
Report
Form 4 Applied Therapeutics, For: Mar 04 Filed by: Funtleyder Leslie D.
3/6
08:30 pm
aplt
Form 4 Applied Therapeutics, For: Mar 04 Filed by: Chinoporos Constantine
High
Report
Form 4 Applied Therapeutics, For: Mar 04 Filed by: Chinoporos Constantine
2/14
06:12 pm
aplt
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: Venrock Healthcare Capital Partners III, L.P.
Medium
Report
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: Venrock Healthcare Capital Partners III, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/8
Applied Therapeutics Announces Positive Topline Results of Pivotal Phase 2 ACTION-Galactosemia Study of AT-007 in Galactosemia Patients
41.5%
1/9 Applied Therapeutics (NASDAQ: APLT) had its price target raised by analysts at Citigroup Inc from $29.00 to $44.00. They now have a "buy" rating on the stock. 25.7%
5/13 Form 3 Applied Therapeutics For: May 13 Filed by: Funtleyder Leslie D. 16.9%
12/23 Form EFFECT Applied Therapeutics 14.4%
4/3 Form 3 Applied Therapeutics For: Apr 01 Filed by: Mahadevan Chids 9.9%
12/19 Form S-1/A Applied Therapeutics 7.3%
1/29 Form 4 Applied Therapeutics For: Jan 28 Filed by: MARCUS JOEL S 7.1%
3/13 Form 8-K Applied Therapeutics For: Mar 13 7.0%
3/3 Applied Therapeutics Appoints Adam Hansard as Chief Commercial Officer 6.5%
6/10 Applied Therapeutics (NASDAQ: APLT) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock. 6.5%
1/9 Applied Therapeutics (NASDAQ: APLT) had its price target raised by analysts at Citigroup Inc from $29.00 to $44.00. They now have a "buy" rating on the stock. 25.7%
5/13 Form 3 Applied Therapeutics For: May 13 Filed by: Funtleyder Leslie D. 16.9%
12/23 Form EFFECT Applied Therapeutics 14.4%
4/3 Form 3 Applied Therapeutics For: Apr 01 Filed by: Mahadevan Chids 9.9%
12/19 Form S-1/A Applied Therapeutics 7.3%
1/29 Form 4 Applied Therapeutics For: Jan 28 Filed by: MARCUS JOEL S 7.1%
3/13 Form 8-K Applied Therapeutics For: Mar 13 7.0%
3/3 Applied Therapeutics Appoints Adam Hansard as Chief Commercial Officer 6.5%
6/10 Applied Therapeutics (NASDAQ: APLT) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock. 6.5%
TOP News Decliners
3/16
Form POS AM Applied Therapeutics
-29.8%
3/10 Applied Therapeutics (NASDAQ: APLT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -13.2%
3/11 Form 4 Applied Therapeutics For: Mar 09 Filed by: Hansard Adam -11.9%
4/21 Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial -11.8%
6/21 Applied Therapeutics Reports First Quarter 2019 Financial Results -11.0%
12/5 Applied Therapeutics Announces Presentations Outlining the Design and Rationale for the ARISE-HF Pivotal Study of AT-001 for Treatment of Diabetic Cardiomyopathy at the 16th Annual Global Cardiovascular Clinical Trialist’s Forum (CVCT) -10.4%
3/31 Form 4 Applied Therapeutics For: Mar 27 Filed by: Alexandria Venture Investments, LLC -10.0%
3/5 Applied Therapeutics (APLT) Investor Presentation - Slideshow [Seeking Alpha] -9.3%
6/5 Form 4 Applied Therapeutics For: Jun 03 Filed by: Funtleyder Leslie D. -9.0%
8/8 Applied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia Study -8.1%
3/10 Applied Therapeutics (NASDAQ: APLT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -13.2%
3/11 Form 4 Applied Therapeutics For: Mar 09 Filed by: Hansard Adam -11.9%
4/21 Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial -11.8%
6/21 Applied Therapeutics Reports First Quarter 2019 Financial Results -11.0%
12/5 Applied Therapeutics Announces Presentations Outlining the Design and Rationale for the ARISE-HF Pivotal Study of AT-001 for Treatment of Diabetic Cardiomyopathy at the 16th Annual Global Cardiovascular Clinical Trialist’s Forum (CVCT) -10.4%
3/31 Form 4 Applied Therapeutics For: Mar 27 Filed by: Alexandria Venture Investments, LLC -10.0%
3/5 Applied Therapeutics (APLT) Investor Presentation - Slideshow [Seeking Alpha] -9.3%
6/5 Form 4 Applied Therapeutics For: Jun 03 Filed by: Funtleyder Leslie D. -9.0%
8/8 Applied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia Study -8.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: